John K. Bakewell - 10 May 2024 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role: Director
Signature: /s/ Lisa O. Taylor as Attorney in Fact for John K. Bakewell
Issuer symbol: TMCI
Transactions as of: 10 May 2024
Net transactions value: +$594,620
Form type: 4
Filing time: 13 May 2024, 19:30:01 UTC
Previous filing: 17 Aug 2023
Next filing: 22 May 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TMCI	Common Stock	Purchase	$594,620	+130,000	+2575%	$4.57	135,048	10 May 2024	Direct	F1, F2
holding	TMCI	Common Stock						250,000	10 May 2024	by spouse as trustee of a trust
holding	TMCI	Common Stock						92,300	10 May 2024	as trustee of a trust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.425 to $4.6186, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
F2	Includes 2,753 restricted stock units.

Content

The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.425 to $4.6186, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

Includes 2,753 restricted stock units.